1. Home
  2. ACON vs NCNA Comparison

ACON vs NCNA Comparison

Compare ACON & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACON
  • NCNA
  • Stock Information
  • Founded
  • ACON 2008
  • NCNA 1997
  • Country
  • ACON United States
  • NCNA United Kingdom
  • Employees
  • ACON N/A
  • NCNA N/A
  • Industry
  • ACON Retail: Computer Software & Peripheral Equipment
  • NCNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACON Technology
  • NCNA Health Care
  • Exchange
  • ACON Nasdaq
  • NCNA Nasdaq
  • Market Cap
  • ACON 4.1M
  • NCNA 4.5M
  • IPO Year
  • ACON 2022
  • NCNA 2017
  • Fundamental
  • Price
  • ACON $7.43
  • NCNA $0.06
  • Analyst Decision
  • ACON Buy
  • NCNA Buy
  • Analyst Count
  • ACON 2
  • NCNA 2
  • Target Price
  • ACON $481.00
  • NCNA $25.00
  • AVG Volume (30 Days)
  • ACON 17.6K
  • NCNA 326.9M
  • Earning Date
  • ACON 08-13-2025
  • NCNA 08-14-2025
  • Dividend Yield
  • ACON N/A
  • NCNA N/A
  • EPS Growth
  • ACON N/A
  • NCNA N/A
  • EPS
  • ACON N/A
  • NCNA N/A
  • Revenue
  • ACON $54,601.00
  • NCNA N/A
  • Revenue This Year
  • ACON $212.31
  • NCNA N/A
  • Revenue Next Year
  • ACON $92.86
  • NCNA N/A
  • P/E Ratio
  • ACON N/A
  • NCNA N/A
  • Revenue Growth
  • ACON N/A
  • NCNA N/A
  • 52 Week Low
  • ACON $6.20
  • NCNA $0.03
  • 52 Week High
  • ACON $3,499.51
  • NCNA $10.79
  • Technical
  • Relative Strength Index (RSI)
  • ACON 44.53
  • NCNA 39.70
  • Support Level
  • ACON $6.79
  • NCNA $0.06
  • Resistance Level
  • ACON $8.19
  • NCNA $0.10
  • Average True Range (ATR)
  • ACON 0.39
  • NCNA 0.02
  • MACD
  • ACON 0.28
  • NCNA 0.01
  • Stochastic Oscillator
  • ACON 45.76
  • NCNA 5.69

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

Share on Social Networks: